Items where Author is "Kirkwood, JM"

Article

Tarhini, AA and Zahoor, H and Yearley, JH and Gibson, C and Rahman, Z and Dubner, R and Rao, UNM and Sander, C and Kirkwood, JM (2015) Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma. Journal of Translational Medicine, 13 (1).

Tarhini, AA and Zahoor, H and Lin, Y and Malhotra, U and Sander, C and Butterfield, LH and Kirkwood, JM (2015) Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for ImmunoTherapy of Cancer, 3 (1).

Villaruz, LC and Huang, G and Romkes, M and Kirkwood, JM and Buch, SC and Nukui, T and Flaherty, KT and Lee, SJ and Wilson, MA and Nathanson, KL and Benos, PV and Tawbi, HA (2015) MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxelbased therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603. Clinical Epigenetics, 7 (1). ISSN 1868-7075

Tarhini, AA and Edington, H and Butterfield, LH and Lin, Y and Shuai, Y and Tawbi, H and Sander, C and Yin, Y and Holtzman, M and Johnson, J and Rao, UNM and Kirkwood, JM (2014) Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab. PLoS ONE, 9 (2).

Pancoska, P and Kirkwood, JM and Bouros, S and Spyropoulou-Vlachou, M and Pectasides, E and Tsoutsos, D and Polyzos, A and Markopoulos, C and Panagiotou, P and Castana, O and Bafaloukos, D and Fountzilas, G and Gogas, H (2014) A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon. PLoS ONE, 9 (1).

Tarhini, AA and Lin, Y and Yeku, O and LaFramboise, WA and Ashraf, M and Sander, C and Kirkwood, JM and Lee, S (2014) A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma. Journal of Translational Medicine, 12 (1).

Ascierto, PA and Grimaldi, AM and Anderson, AC and Bifulco, C and Cochran, A and Garbe, C and Eggermont, AM and Faries, M and Ferrone, S and Gershenwald, JE and Gajewski, TF and Halaban, R and Stephen Hodi, F and Kefford, R and Kirkwood, JM and Larkin, J and Leachman, S and Maio, M and Marais, R and Masucci, G and Melero, I and Palmieri, G and Puzanov, I and Ribas, A and Saenger, Y and Schilling, B and Seliger, B and Stroncek, D and Sullivan, R and Testori, A and Wang, E and Ciliberto, G and Mozzillo, N and Marincola, FM and Thurin, M (2014) Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013. Journal of Translational Medicine, 12 (1).

Jilaveanu, LB and Zhao, F and Zito, CR and Kirkwood, JM and Nathanson, KL and D'Andrea, K and Wilson, M and Rimm, DL and Flaherty, KT and Lee, SJ and Kluger, HM (2013) Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel. PLoS ONE, 8 (8).

Ho, J and de Moura, MB and Lin, Y and Vincent, G and Thorne, S and Duncan, LM and Hui-Min, L and Kirkwood, JM and Becker, D and Van Houten, B and Moschos, SJ (2012) Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Molecular Cancer, 11.

Sigalotti, L and Covre, A and Fratta, E and Parisi, G and Sonego, P and Colizzi, F and Coral, S and Massarut, S and Kirkwood, JM and Maio, M (2012) Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. Journal of Translational Medicine, 10 (1).

Barbi de Moura, M and Vincent, G and Fayewicz, SL and Bateman, NW and Hood, BL and Sun, M and Suhan, J and Duensing, S and Yin, Y and Sander, C and Kirkwood, JM and Becker, D and Conrads, TP and van Houten, B and Moschos, SJ (2012) Mitochondrial respiration - an important therapeutic target in melanoma. PLoS ONE, 7 (8).

Wang, E and Zhao, Y and Monaco, A and Uccellini, L and Kirkwood, JM and Spyropoulou-Vlachou, M and Panelli, MC and Marincola, FM and Gogas, H (2012) A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon. PLoS ONE, 7 (7).

Ascierto, PA and Kirkwood, JM and Grob, JJ and Simeone, E and Grimaldi, AM and Maio, M and Palmieri, G and Testori, A and Marincola, FM and Mozzillo, N (2012) The role of BRAF V600 mutation in melanoma. Journal of Translational Medicine, 10 (1).

Ascierto, PA and Grimaldi, AM and Curti, B and Faries, MB and Ferrone, S and Flaherty, K and Fox, BA and Gajewski, TF and Gershenwald, JE and Gogas, H and Grossmann, K and Hauschild, A and Hodi, FS and Kefford, R and Kirkwood, JM and Leachmann, S and Maio, M and Marais, R and Palmieri, G and Morton, DL and Ribas, A and Stroncek, DF and Stewart, R and Wang, E and Mozzillo, N and Marincola, FM (2012) FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the "Melanoma Research: A bridge from Naples to the World. Napoli, December 5 ^th-6 ^th2011". Journal of Translational Medicine, 10 (1).

Sigalotti, L and Fratta, E and Bidoli, E and Covre, A and Parisi, G and Colizzi, F and Coral, S and Massarut, S and Kirkwood, JM and Maio, M (2011) Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients. Journal of Translational Medicine, 9.

Simons, DL and Lee, G and Kirkwood, JM and Lee, PP (2011) Interferon signaling patterns in peripheral blood lymphocytes may predict clinical outcome after high-dose interferon therapy in melanoma patients. Journal of Translational Medicine, 9.

Ascierto, PA and De Maio, E and Bertuzzi, S and Palmieri, G and Halaban, R and Hendrix, M and Kashani-sabet, M and Ferrone, S and Wang, E and Cochran, A and Rivoltini, L and Lee, PP and Fox, BA and Kirkwood, JM and Ullmann, CD and Lehmann, FF and Sznol, M and Schwartzentruber, DJ and Maio, M and Flaherty, K and Galon, J and Ribas, A and Yang, J and Stroncek, DF and Mozzillo, N and Marincola, FM (2011) Future perspectives in melanoma research. Meeting report from the "Melanoma Research: A bridge Naples-USA. Naples, December 6^th-7 ^th2010". Journal of Translational Medicine, 9.

Butterfield, LH and Potter, DM and Kirkwood, JM (2011) Multiplex serum biomarker assessments: technical and biostatistical issues. Journal of translational medicine, 9. 173 - ?.

Ascierto, PA and Napolitano, M and Celentano, E and Simeone, E and Gentilcore, G and Daponte, A and Capone, M and Caracò, C and Calemma, R and Beneduce, G and Cerrone, M and De Rosa, V and Palmieri, G and Castello, G and Kirkwood, JM and Marincola, FM and Mozzillo, N (2010) Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-α 2b treatment. Journal of Translational Medicine, 8.

Gogas, H and Dafni, U and Koon, H and Spyropoulou-Vlachou, M and Metaxas, Y and Buchbinder, E and Pectasides, E and Tsoutsos, D and Polyzos, A and Stratigos, A and Markopoulos, C and Panagiotou, P and Fountzilas, G and Castana, O and Skarlos, P and Atkins, MB and Kirkwood, JM (2010) Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial. Journal of Translational Medicine, 8.

Ding, Y and Larson, G and Rivas, G and Lundberg, C and Geller, L and Ouyang, C and Weitzel, J and Archambeau, J and Slater, J and Daly, MB and Benson, AB and Kirkwood, JM and O'Dwyer, PJ and Sutphen, R and Stewart, JA and Johnson, D and Nordborg, M and Krontiris, TG (2008) Strong signature of natural selection within an FHIT intron implicated in prostate cancer risk. PLoS ONE, 3 (10).